Hospira
Investor RelationsNewsroomCareersIn the Community
United States
  • Products + Services
    • Drugs
    • IV Sets
    • IV Clinical Integration
    • Infusion Pumps
    • Clinical Software
    • Implementation Services
    • Clinical Services
    • Contract Manufacturing
  • Healthcare Trends
    • Supply Costs
    • Medication Errors
    • IV Clinical Integration
    • Healthcare Associated Infections
    • Caregiver Safety
  • Support Center
    • Support - Infusion Pumps + Software
    • Order + Sales Support
    • Medical Affairs + Information
    • Clinical Bulletins
    • Customer Communications
  • About Hospira
    • Our Philosophy
    • Our History
    • Leadership
    • Awards + Recognition
    • Supplier Information
    • Newsroom
    • Investor Relations
    • Government Affairs
    • In the Community
    • Careers
    • Investor Relations
    • Press Releases
    Email Print

    Press Releases

     

    All Releases | Reset Search
    Acquisitions | Business/Product | Corporate | Financial

    2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
    DateTitle 
    05/14/13Hospira Reappoints Dr. Sumant Ramachandra Chief Scientific OfficerPrinter Friendly Version
    05/08/13Hospira Convenes Its 2013 Annual Meeting of ShareholdersPrinter Friendly Version
    05/01/13Hospira Reports First-Quarter 2013 ResultsPrinter Friendly Version
    05/01/13Hospira Unveils Global Device StrategyPrinter Friendly Version
    04/24/13Hospira Marks Five Years of Biosimilars Success at 2013 BIO International ConventionPrinter Friendly Version
    04/17/13Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
    04/15/13Hospira Names Matthew R. Stober Senior Vice President of OperationsPrinter Friendly Version
    04/02/13Hospira to Host Conference Call for First-Quarter 2013 ResultsPrinter Friendly Version
    03/18/13Hospira Obtains Six Months U.S. Pediatric Exclusivity for Precedex™ (dexmedetomidine HCl) InjectionPrinter Friendly Version
    03/18/13Hospira Statement on Rocky Mount Plant InspectionPrinter Friendly Version
    03/01/13Hospira Announces Executive ChangesPrinter Friendly Version
    02/13/13Hospira Reports Fourth-Quarter and Full-Year 2012 ResultsPrinter Friendly Version
    02/05/13Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
    01/23/13Hospira's TheraDoc™ Infection Control Assistant Ranked #1 in Its Category in the Latest "Best in KLAS" ReportPrinter Friendly Version
    01/22/13Hospira and Q Core Medical Sign International Distribution Agreement for Sapphire Infusion SystemPrinter Friendly Version

    Investing Overview

    • Shareholder Information
    • Stock Quote / Chart
    • Shareholder FAQ
    • Analyst Coverage
    • Information Request

    Financial Reports

    • Annual Reports / Proxies
    • Quarterly Reports / Supplemental Tables
    • Proxy Materials
    • SEC Filings
    • Insider Transactions

    News & Events

    • Press Releases
    • Presentations
    • Event Calendar
    • Email Alerts

    Corporate Governance

    • Hospira Leadership
    • Board of Directors
    • Board Committees and Charters
    • Corporate Governance Guidelines
    • Share Ownership Guidelines
    • Long Term Incentives Policy
    • Hospira Code of Business Conduct

    Investor Toolkit

    IR Contacts
    Email Alerts
    RSS Feeds
    Products + Services
    • Drugs
    • IV Sets
    • IV Clinical Integration
    • Infusion Pumps
    • Clinical Software
    • Implementation Services
    • Clinical Services
    • Contract Manufacturing
    • Drugs A-Z
    • Export Product Catalog
    • Buy at e.Hospira.com
    • Solution Center
    • Lidocaine
    • Sodium Bicarbonate
    • Sodium Chloride
    • Ketorolac
    • Morphine
    Healthcare Trends
    • Supply Costs
    • Medication Errors
    • IV Clinical Integration
    • Healthcare Associated Infections
    • Caregiver Safety
    Support Center
    • Support - Infusion Pumps + Software
    • Order + Sales Support
    • Medical Affairs + Information
    • Clinical Bulletins
    • Customer Communications
    About Hospira
    • Our Philosophy
    • Our History
    • Leadership
    • Awards + Recognition
    • Supplier Information
    • Newsroom
    • Investor Relations
    • Government Affairs
    • In the Community
    • Careers
    Follow Hospira
    • Follow us on Twitter
    • Follow us on YouTube
    • Follow us on LinkedIn
    Utility
    • Legal Notice
    • Privacy Policy
    • Compliance
    • Terms + Conditions
    © Hospira, Inc. This website and its information is intended for use by United States residents only. Regulatory requirements, data requirements or medical practices may differ between countries. Therefore, information on this site may be inappropriate for use outside of the United States. Site contents are intended for informational purposes only and not intended to replace discussion with a healthcare provider. If you have any questions regarding this site, contact Hospira.